Exposure to placental ischemia impairs postpartum maternal renal and cardiac function in rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 312, Issue 5, 2017, Pages R664-R670

  Paauw, Nina D ^a   Joles, Jaap A ^b   Spradley, Frank T ^c   Bakrania, Bhavisha ^c   Zsengeller, Zsuzsanna K ^d   Franx, Arie ^a   Verhaar, Marianne C ^b   Granger, Joey P ^c   Lely, A Titia ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cardiac function; Glomerular filtration rate; Placental ischemia; Postpartum; Preeclampsia

Indexed keywords

VASCULOTROPIN RECEPTOR 1;

ALBUMINURIA; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH STATUS; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TISSUE; HISTOLOGY; INTRAUTERINE PRESSURE; ISCHEMIA; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY MASS; KIDNEY STRUCTURE; KIDNEY TISSUE; MEAN ARTERIAL PRESSURE; MESENTERIC ARTERY; NONHUMAN; PERFUSION PRESSURE; PLACENTA DISORDER; PLACENTA ISCHEMIA; PREECLAMPSIA; PRIORITY JOURNAL; PUERPERIUM; RAT; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; URINE SAMPLING; VASODILATATION; WEIGHT GAIN; ANIMAL; COMPLICATION; HEART DISEASES; HEART FUNCTION TEST; KIDNEY DISEASES; MATERNAL EXPOSURE; PATHOPHYSIOLOGY; PLACENTA; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL EXPOSURE; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; FEMALE; GLOMERULAR FILTRATION RATE; HEART DISEASES; HEART FUNCTION TESTS; ISCHEMIA; KIDNEY DISEASES; MATERNAL EXPOSURE; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 85018306391     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00510.2016     Document Type: Article

References (40)

1. Alexander BT, Kassab SE, Miller MT, Abram SR, Reckelhoff JF, Bennett WA, Granger JP. Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. Hypertension 37: 1191–1195, 2001. doi:10. 1161/01.HYP.37.4.1191.
2. Berks D, Steegers EA, Molas M, Visser W. Resolution of hypertension and proteinuria after preeclampsia. Obstet Gynecol 114: 1307–1314, 2009. doi:10.1097/AOG.0b013e3181c14e3e.
3. Brennan L, Morton JS, Quon A, Davidge ST. Postpartum vascular dysfunction in the reduced uteroplacental perfusion model of preeclampsia. PLoS One 11: e0162487, 2016. doi:10.1371/journal.pone.0162487.
4. Brown MC, Best KE, Pearce MS, Waugh J, Robson SC, Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol 28: 1–19, 2013. doi:10.1007/s10654-013-9762-6.
5. Bytautiene E, Bulayeva N, Bhat G, Li L, Rosenblatt KP, Saade GR. Long-term alterations in maternal plasma proteome after sFlt1-induced preeclampsia in mice. Am J Obstet Gynecol 208: 388.e1–388.e10, 2013. doi:10.1016/j.ajog.2013.01.042.
6. Bytautiene E, Lu F, Tamayo EH, Hankins GD, Longo M, Kublickiene K, Saade GR. Long-term maternal cardiovascular function in a mouse model of sFlt-1-induced preeclampsia. Am J Physiol Heart Circ Physiol 298: H189–H193, 2010. doi:10.1152/ajpheart.00792.2009.
7. Chambers JC, Fusi L, Malik IS, Haskard DO, De Swiet M, Kooner JS. Association of maternal endothelial dysfunction with preeclampsia. JAMA 285: 1607–1612, 2001. doi:10.1001/jama.285.12.1607.
8. Fogo A, Ichikawa I. Evidence for a pathogenic linkage between glomerular hypertrophy and sclerosis. Am J Kidney Dis 17: 666–669, 1991. doi:10.1016/S0272-6386(12)80347-7.
9. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension 38: 718–722, 2001. doi:10.1161/01.HYP.38.3.718.
10. Gutkowska J, Granger JP, Lamarca BB, Danalache BA, Wang D, Jankowski M. Changes in cardiac structure in hypertension produced by placental ischemia in pregnant rats: effect of tumor necrosis factor blockade. J Hypertens 29: 1203–1212, 2011. doi:10.1097/HJH. 0b013e3283468392.
11. Heida KY, Franx A, van Rijn BB, Eijkemans MJ, Boer JM, Verschuren MW, Oudijk MA, Bots ML, van der Schouw YT. Earlier age of onset of chronic hypertension and type 2 diabetes mellitus after a hypertensive disorder of pregnancy or gestational diabetes mellitus. Hypertension 66: 1116–1122, 2015.10.1161/HYPERTENSIONAHA.115. 06005.
12. Hoy WE, Bertram JF, Denton RD, Zimanyi M, Samuel T, Hughson MD. Nephron number, glomerular volume, renal disease and hypertension. Curr Opin Nephrol Hypertens 17: 258–265, 2008. doi:10.1097/MNH.0b013e3282f9b1a5.
13. Hubel CA, Wallukat G, Wolf M, Herse F, Rajakumar A, Roberts JM, Markovic N, Thadhani R, Luft FC, Dechend R. Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension 49: 612–617, 2007. doi:10.1161/01.HYP. 0000256565.20983.d4.
14. Joles JA, van Goor H, Koomans HA. Estrogen induces glomerulosclerosis in analbuminemic rats. Kidney Int 53: 862–868, 1998. doi:10.1111/j.1523-1755.1998.00825.x.
15. Kvehaugen AS, Dechend R, Ramstad HB, Troisi R, Fugelseth D, Staff AC. Endothelial function and circulating biomarkers are disturbed in women and children after preeclampsia. Hypertension 58: 63–69, 2011. doi:10.1161/HYPERTENSIONAHA.111.172387.
16. Li J, LaMarca B, Reckelhoff JF. A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model. Am J Physiol Heart Circ Physiol 303: H1–H8, 2012. doi:10.1152/ajpheart.00117.2012.
17. Mangos GJ, Spaan JJ, Pirabhahar S, Brown MA. Markers of cardiovascular disease risk after hypertension in pregnancy. J Hypertens 30: 351–358, 2012. doi:10.1097/HJH.0b013e32834e5ac7.
18. Martillotti G, Ditisheim A, Burnier M, Wagner G, Boulvain M, Irion O, Pechère-Bertschi A. Increased salt sensitivity of ambulatory blood pressure in women with a history of severe preeclampsia. Hypertension 62: 802–808, 2013. doi:10.1161/HYPERTENSIONAHA.113.01916.
19. Matsui K, Nagy-Bojarsky K, Laakkonen P, Krieger S, Mechtler K, Uchida S, Geleff S, Kang DH, Johnson RJ, Kerjaschki D. Lymphatic microvessels in the rat remnant kidney model of renal fibrosis: aminopeptidase p and podoplanin are discriminatory markers for endothelial cells of blood and lymphatic vessels. J Am Soc Nephrol 14: 1981–1989, 2003. doi:10.1097/01.ASN.0000076078.50889.43.
20. McDonald SD, Han Z, Walsh MW, Gerstein HC, Devereaux PJ. Kidney disease after preeclampsia: a systematic review and meta-analysis. Am J Kidney Dis 55: 1026–1039, 2010. doi:10.1053/j.ajkd.2009.12.036.
21. Melchiorre K, Sutherland GR, Liberati M, Thilaganathan B. Preeclampsia is associated with persistent postpartum cardiovascular impairment. Hypertension 58: 709–715, 2011. doi:10.1161/HYPERTENSIONAHA.111. 176537.
22. Orabona R, Vizzardi E, Sciatti E, Bonadei I, Valcamonico A, Metra M, Frusca T. Insights into cardiac alterations after pre-eclampsia: an echocardiographic study. Ultrasound Obstet Gynecol, 49: 124–133, 2016. doi:10.1002/uog.15983.
23. Pruthi D, Khankin EV, Blanton RM, Aronovitz M, Burke SD, McCurley A, Karumanchi SA, Jaffe IZ. Exposure to experimental preeclampsia in mice enhances the vascular response to future injury. Hypertension 65: 863–870, 2015. doi:10.1161/HYPERTENSIONAHA.114. 04971.
24. Romundstad PR, Magnussen EB, Smith GD, Vatten LJ. Hypertension in pregnancy and later cardiovascular risk: common antecedents? Circulation 122: 579–584, 2010. doi:10.1161/CIRCULATIONAHA.110. 943407.
25. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 325: 157–160, 2002. doi:10.1136/bmj.325.7356.157.
26. Saxena AR, Karumanchi SA, Brown NJ, Royle CM, McElrath TF, Seely EW. Increased sensitivity to angiotensin II is present postpartum in women with a history of hypertensive pregnancy. Hypertension 55: 1239–1245, 2010. doi:10.1161/HYPERTENSIONAHA.109.147595.
27. Schock-Kusch D, Sadick M, Henninger N, Kraenzlin B, Claus G, Kloetzer HM, Weiss C, Pill J, Gretz N. Transcutaneous measurement of glomerular filtration rate using FITC-sinistrin in rats. Nephrol Dial Transplant 24: 2997–3001, 2009. doi:10.1093/ndt/gfp225.
28. Sholook MM, Gilbert JS, Sedeek MH, Huang M, Hester RL, Granger JP. Systemic hemodynamic and regional blood flow changes in response to chronic reductions in uterine perfusion pressure in pregnant rats. Am J Physiol Heart Circ Physiol 293: H2080–H2084, 2007. doi:10.1152/ajpheart.00667.2007.
29. Spaan JJ, Ekhart T, Spaanderman ME, Peeters LL. Reduced renal function after preeclampsia does not result from accelerated age-dependent renal function loss. Acta Obstet Gynecol Scand 89: 1202–1205, 2010. doi:10.3109/00016349.2010.484043.
30. Spaanderman ME, Ekhart TH, de Leeuw PW, Peeters LL. Angiotensin II sensitivity in nonpregnant formerly preeclamptic women and healthy parous controls. J Soc Gynecol Investig 11: 416–422, 2004. doi:10.1016/j.jsgi.2004.06.003.
31. Spradley FT, Palei AC, Granger JP. Obese melanocortin-4 receptordeficient rats exhibit augmented angiogenic balance and vasorelaxation during pregnancy. Physiol Rep 1: e00081, 2013. doi:10.1002/phy2.81.
32. Suzuki H, Watanabe Y, Arima H, Kobayashi K, Ohno Y, Kanno Y. Short- and long-term prognosis of blood pressure and kidney disease in women with a past history of preeclampsia. Clin Exp Nephrol 12: 102– 109, 2008. doi:10.1007/s10157-007-0018-1.
33. Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, Zeeman GG, Brown MA. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens 4: 97–104, 2014. doi:10.1016/j.preghy. 2014.02.001.
34. van der Graaf AM, Toering T, Van der Wiel MK, Navis G, Buikema H, Lely AT, Faas MM. Angiotensin II sensitivity after preeclampsia in human and rat (Abstract). Reprod Sci 21: 402A, 2014.
35. van Rijn BB, Nijdam ME, Bruinse HW, Roest M, Uiterwaal CS, Grobbee DE, Bots ML, Franx A. Cardiovascular disease risk factors in women with a history of early-onset preeclampsia. Obstet Gynecol 121: 1040–1048, 2013. doi:10.1097/AOG.0b013e31828ea3b5.
36. Vikse BE, Irgens LM, Karumanchi SA, Thadhani R, Reisæter AV, Skjærven R. Familial factors in the association between preeclampsia and later ESRD. Clin J Am Soc Nephrol 7: 1819–1826, 2012. doi:10.2215/CJN.01820212.
37. Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM. Preeclampsia and the risk of end-stage renal disease. N Engl J Med 359: 800–809, 2008. doi:10.1056/NEJMoa0706790.
38. Wang IK, Muo CH, Chang YC, Liang CC, Chang CT, Lin SY, Yen TH, Chuang FR, Chen PC, Huang CC, Wen CP, Sung FC, Morisky DE. Association between hypertensive disorders during pregnancy and end-stage renal disease: a population-based study. CMAJ 185: 207–213, 2013. doi:10.1503/cmaj.120230.
39. Weissgerber TL, Milic NM, Milin-Lazovic JS, Garovic VD. Impaired flow-mediated dilation before, during, and after preeclampsia: a systematic review and meta-analysis. Hypertension 67: 415–423, 2016. doi:10.1161/HYPERTENSIONAHA.115.06554.
40. Wu CC, Chen SH, Ho CH, Liang FW, Chu CC, Wang HY, Lu YH. End-stage renal disease after hypertensive disorders in pregnancy. Am J Obstet Gynecol 210: 147.e1–147.e8, 2014. doi:10.1016/j.ajog.2013.09. 027.